“bristol-myers-squibb” Archives

in
Entry Author Date Location
Bio Roundup: Skinny Cuts, Genomic Approvals, Unfrozen FDA & More 05/26/17 National
FDA Landmark Nod: Cancer Drug To Match Tumor Genes, Not Tissue Type 05/23/17 National
Not Resting on Hemophilia Biz, Bioverativ Pays $400M For True North 05/23/17 Boston
With Latest Deal, Biogen Bets $120M on Remedy Pharma Stroke Drug 05/15/17 Boston
Merck Immunotherapy Drug Notches Another FDA Win in Lung Cancer 05/11/17 New York
Genentech Drug Fails to Beat Chemo in Treating Advanced Bladder Cancer 05/10/17 San Francisco
With $75M Haul, Ovid Continues Flurry of Biotech IPOs 05/04/17 New York
Bio Roundup: CRISPR Appeal, Bristol Deals, Stock Pumping & More 04/14/17 National
Bristol Flips Remnants of Adnexus, iPierian to Roche, Biogen For $470M 04/13/17 New York
With Ovid IPO, Ex-Teva CEO Levin Pitches Neuro Drug Plan to Wall Street 04/11/17 New York
AACR Review: Biden Fired Up, Incyte Doubles Up, BMS Up And Down 04/06/17 National
Bio Roundup: Trumpcare Wavers, Amgen Courts Payers, Critics Circle PTC 03/24/17 National
First Trial Underway, CytomX Gets $200M More In Expanded Bristol Pact 03/20/17 San Francisco
Possible Cures. Mystery Deaths. Daunting Costs. Can CAR-T Be Tamed? 03/13/17 National
Biotech Roundup: Obamacare Lite, DePinho Out, Dunsire In & More 03/10/17 National
Drugmakers, Amazon Back Grail’s Big Cancer Trials With $900M 03/01/17 San Francisco
At Arrakis, Gilman Teams With Biogen Vets to Target RNA With Pills 02/27/17 Boston
Bio Roundup: Trump Backlash, Verdine Plans, Sarepta Sale & More 02/24/17 National
Bio Roundup: Tom Price, Patient Conflicts, Orphan Games & More 01/20/17 National
Neon Therapeutics Hauls in $70M for Personalized Cancer Vaccines 01/05/17 Boston
First Trial Underway, Jounce Preps IPO To Fund Immuno-Oncology Work 01/03/17 Boston
Bio Roundup: Crazy ’16, Trials of ’17, Senate on Drugs & More 12/23/16 National
Bio Roundup: NY Rises, Prez Inks Cures, Ophthotech Crashes & More 12/16/16 National
ASH Roundup: CAR-T Shuffle, Hemophilia Updates, Checkpoint Progress & More 12/06/16 National
Bio Roundup: Trump’s Rx Silence, PCSK9 News, Amgen’s Migraines & More 11/18/16 National
Struggling UniQure Cuts Gene Therapies, Jobs, in Big Restructuring 11/15/16 Boston
Bio Roundup: Trump’s Triumph, Election Fallout, CRISPR Arguments & More 11/11/16 National
FDA: Keytruda Now OK For Some Patients With Untreated Lung Cancer 10/25/16 National
Bio Roundup: Bristol & Illumina Blues, Sickle Cell News & More 10/14/16 National
Inspyr Leaves San Antonio for California to Be Near Clinical Trials 10/12/16 Texas
Page 1 of 14 next page »